Apollomics Inc. (APLM) stock

APLMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as APLMW

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 24, 2026Score 0/30

$17.68+0.38 (+2.20%)

Close on Nov 13, 2026Market cap $38.83MP/E –Yield –

Apollomics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Apollomics's total debt was $0 at Dec 31, 2024. For fiscal 2024 it was $0, down 100.0% from the year before.

Period	Period end	Value	Change
FY2024	Dec 31, 2024	$0	-100.0%
FY2023	Dec 31, 2023	$4.24M	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q4 FY2024	Dec 31, 2024	$0	–
Q2 FY2024	Jun 30, 2024	$3.51M	–
Q4 FY2023	Dec 31, 2023	$4.24M	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is APLM.

Advertisement
300 × 250

See a number that looks wrong?